For this assigments: I choose the Rotavirus and MRSA infections. I work as a Registered Nurse in a hospital, and I see this infection presented in patients often. The diseases can spread easily and can lead to serious complications if precautions are not implemented. As a nurse working in a hospital, I often see rotavirus and Methicillin-Resistant Staphylococcus aureus (MRSA) in healthcare settings. These diseases spread easily and can lead to serious complications. I am from Venezuela and now working in the United States has shown me how differences in healthcare access and socioeconomic conditions can affect patient outcomes.
Submit a disease pathology, management, and pharmacological impact summary based on your two chosen diseases. Your summary should explain the characteristics of the infectious agent causing the diseases, the lab tests used for identification, and the mechanism in which the diseases interfere with normal pathophysiology. You will also describe current treatment trends used in the management of the diseases, identify which class of drug has the most evidence to support its use in the pharmacological treatments, illustrate the mechanisms the pharmacological treatments use to combat infection, and explain how preventative and protective measures can be enhanced for each disease to reduce infection and disease transmission. '
Specifically, the following critical elements must be addressed:
I. Disease Pathology
A. Describe the characteristics of infectious agent causing diseases, including structure and toxicities.
B. Describe lab tests used for identification of the chosen organisms.
C. Explain the mechanism in which the diseases interfere with normal pathophysiology. Be sure to describe how the infectious agent enters the cell and establishes infection in the nucleus.
D. Identify signs and symptoms of disease presentation for clinical diagnostics in support of therapeutic interventions for both diseases.
II.Disease Management and Pharmacological Impact
A. Describe pharmacological and nonpharmacological current treatment trends used to control microbial growth for each disease, and explain how such treatments promote patient care.
B. Determine which class of drug has the most evidence to support its use in the pharmacological treatment of each disease, providing a rationale.
C. Illustrate the mechanism and principles these pharmacological treatments use to combat infection.
D. Explain how preventative and protective measures can be enhanced for each disease to effectively reduce infection rates and disease transmission, supported by research.
What to Submit: Milestone Two should be 1 to 2 pages in length. Write one page for each disease. Use double-spacing, 12-point Times New Roman font, and one-inch margins. All citations should follow proper APA guidelines.
References
Centers for Disease Control and Prevention. (2024). About Rotavirus. https://www.cdc.gov/rotavirus/about/
Centers for Disease Control and Prevention. (2025). Methicillin-Resistant Staphylococcus aureus (MRSA) Basics. https://www.cdc.gov/mrsa/about/index.html
Also, you can use the book attached for more reference information.